This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
From AI models that boost sales to robots that slash production costs, advanced technologies are transforming both top-line growth and bottom-line efficiency. Business leaders dont need to be technology experts to grasp this shift; they need vision and urgency. Today, that timeline is shrinking dramatically.
Gains go to states with heavily funded generativeAI startups There are, of course, many complex dynamics at play in determining why a particular state or metro area might see its startup investment fortunes rise or fall. However, in 2024 there was also a simple explanation for the funding pattern: generativeAI.
The largest was a $275 million January Series F for Innovaccer , a San Francisco startup that makes an AI-enabled cloud tracking platform for healthcare providers. And last week, Abridge , an AI-driven platform for clinician conversations, picked up a $250 million Series D.
The new round is bigger than the $6 billion round Elon Musk ’s generativeAI startup, xAI , officially announced in May, which up to this point was the largest round raised this year. Pacific Fusion , $900M, energy: Another huge AI-related round. Seaport Therapeutics , $225M, biotech: Seaport Therapeutics isn’t new to this list.
Wonder ’s big $700 million raise may have captured most people’s attention last month, but the story when it came for large deals was really biotech. Mirador Therapeutics , $400M, biotech: It was a huge month for big biotech raises and this was the biggest. Check out the biggest rounds of last month here.
Of course, it was led by two well-known AI startups — including xAI , which had its second massive haul of cash in just six months. xAI , $5B, artificial intelligence: GenerativeAI startup xAI raised $5 billion in a funding round valuing it at $50 billion, The Wall Street Journal reported.
Zero-based budgeting: A proven framework for extending runway 5 strategies for biotech startups to outlast a market downturn Image Credits: Getty Images Spinning up a biotech company is a massive undertaking. “The best founders look for a framework to strategically cut burn while keeping their startup’s value drivers functioning.”
We featured generativeAI companies five years before the popular investors took notice and climate tech 2.0 Clean tech – Tied in with the biotech trend, we’re seeing a continued surge in input/output companies that process waste to produce byproducts like energy and potable water. It’s a big new data rush.
The retail industry has no shortage of cases on display where generativeAI has shown tangible benefits. They had ChatGPT write the script, and other gen AI tools to create a digital person who reads the script, a scalable process with at least one measurable benefit: speed. And software code is a language.”
Today we worry this phenomenon is playing out with enterprise adoption of generativeAI. GenerativeAI (genAI) arrived on the scene with use cases such as “support chatbots” or “talk to your documentation apps” that were so obviously useful that many companies are well on their way to taking them into production.
Metsera , $290M, biotech: This week was a slower week than normal for biotech — as it was for most sectors — but that didn’t stop New York-based Metsera. Rivos , $250M, semiconductor: Semiconductor startups are seeing big money, in part thanks to the explosion in generativeAI.
April also saw a half-dozen rounds of a quarter-billion dollars or more, including a $1 billion round for an AI-enhanced biotech. Xaira Therapeutics , $1B, biotech: The biggest round in April was really big. The company develops power-optimized chips targeting the data analytics and generativeAI markets.
Biotech and AI had another strong week, as the sectors saw two big nine-figure rounds each — including one for $370 million in biotech. Candid Therapeutics , $370M, biotech: Every week there’s a big biotech raise — and this week there’s one that’s really big. Check out last week’s biggest funding rounds here.
A proposed California bill that has proven controversial in the industry is looking to put safety regulations and guardrails on AI — although many companies, including OpenAI, worry it may be too burdensome to many AI firms. Sakana AI locked up a $100 million round led by Khosla Ventures , Lux Capital and New Enterprise Associates.
While GenerativeAI is buzzy right now, what OpenAI, Microsoft and Google are doing may be only part of the story. The company says it is already in the process of fulfilling orders for its technology. We’re still in the early days of this technology,” he added.
Eight startups raised $100 million or more this week as a biotech and financial services company led the way. Yep, no huge AI raise. Tekion , $200M, automotive: Providing a software platform to the retail automotive industry may not be the sexiest of technology plays, but it obviously can make a valuable company.
Pika is part of a growing group of startups building text-to-video AI software. tied) Prolific Machines , $55M, biotech: Unlike in previous weeks, there was no huge biotech round. The startup plays at a unique intersection of healthcare/biotech, AI and 3D technology. Founded in 2020, Prolific has raised $86.5
Formation Bio , $372M, biotech: Every week there is a big biotech raise and this week’s is really big. Formation Bio, an AI-enhanced pharma company, raised a $372 million Series D led by a16z. More and more biotech startups are using AI to help with their drug processes and investors are clearly taking note.
Biting into an AI Apple : Apple isn’t about to let all those other big tech companies get in on the AI fun. A new story, also by Ivan , reports that Apple is reportedly experimenting with language-generatingAI so that Siri can better understand queries. Alex found some bullish news for software companies. Big Tech Inc.
Key Takeaways from BioTechX 2024: A Shift Towards Realism and Practical Applications Capgemini Nov 6, 2024 Facebook Linkedin The BioTechX event in Basel in October was a major gathering for biotech and pharma professionals. Last year, we were all about the potential of large language models and generativeAI.
xAI , $6B, artificial intelligence: Elon Musk ’s generativeAI startup, xAI, officially announced its long-awaited fundraise — making it the second-most-valuable generativeAI company in the world behind only competitor OpenAI. among others. among others. The xAI round had been rumored for months. just earlier this year.
The slowdown in venture funding has continued despite the AItechnology wave that has washed over startups in the past few years. Top sectors Biotech and healthcare was the leading sector by funding amount in April. AI companies raised $3.9 Of the $22 billion invested in startups globally last month, around $2.4
The new round is bigger than the $6 billion round Elon Musk ’s generativeAI startup, xAI , officially announced in May — which was the largest round raised this year. Kailera Therapeutics , $400M, biotech: Biotech was even bigger this week than normal. Poolside has raised $626 million since being founded in May 2023.
The quintet that did raise big were from three of the usual sectors — biotech, energy and AI — however one was from a sector we don’t normally see — a vertical farming agtech startup. FogPharma , $145M, biotech: It sure feels like this will be a big year for biotech startups, as a few make this list every week.
While there were no huge rounds like last week, money was again spread around from AI to biotech to marketing and more. Celestial AI , $175M, semiconductors: Optical interconnectivity startup Celestial AI raised a massive $175 million Series C led by Thomas Tull ’s US Innovative Technology Fund.
Investors certainly put their money everywhere, from biotech to productivity tools, but they didn’t shell out a lot. Pathalys Pharma , $105M, biotech: Raleigh, North Carolina-based Pathalys Pharma isn’t new to this list — it topped it early last year. Another slow week with only three companies raising rounds of more than $100 million.
Formation Bio , $372M, biotech: Formation Bio, an AI-enhanced pharma company, raised a $372 million Series D led by a16z. More and more biotech startups are using AI to help with their drug processes and investors are clearly taking note. Founded in 2011, the company has raised $1.4 billion, per Crunchbase.
Table of contents Adieu, Q4 Late stage and technology growth Early stage Seed stage Exits M&A IPOs The big picture Methodology Glossary of funding terms Adieu, Q4 The fourth quarter of 2023 was particularly weak in comparison to recent prior quarters. For the fourth quarter, the largest early-stage rounds hailed from the biotech space.
That included more than $200 million for a security company and lots of big biotech raises. NinjaOne , $232M, security : NinjaOne showed this week that not all big funding rounds go to generativeAI companies. Neurona Therapeutics , $120M, biotech: San Francisco-based Neurona Therapeutics was the big biotch winner this week.
Xscape Photonics — a New York-based startup also using photonics technology to address the energy, performance and scalability challenges of AI data centers — raised a $44 million Series A led by IAG Capital Partners with investment from the likes of Cisco Investments and Nvidia.
The company leverages generativeAI in developing software to help customers create driver-assistance systems and automated driving solutions. Zephyr AI , $111M, biotech: Mclean, Virginia-based healthcare startup Zephyr AI closed a $111 million Series A from investors that included Revolution Growth and Eli Lilly & Company.
Four main categories for big AI fundraisers GenerativeAI remains the buzziest space for startup funding, so it’s not surprising to see the largest fundraising recipients fall in this category. Next up in the gen AI category are Anthropic , with $8.4 Editor’s note: The list includes Inflection AI.
Table of contents Late stage and technology growth Early stage Seed stage Exits IPOs M&A The big picture Methodology Glossary of funding terms Late stage and technology growth We’ll start with late-stage dealmaking, which still attracts more money than any other stage, even at the current, somewhat depressed levels.
Hundreds of professional futurists now work in government, academia and other sectors, analyzing demographic, technological and climatic trends to envision what life will look like years from now. It wasn’t surprising, for instance, to see that generativeAI has been a popular area for seed investors. Some were obvious.
The startup is a provider of Nvidia ’s latest GPUs, which are highly sought after by AI developers. The round was led by Thomas Tull ’s US Innovative Technology Fund. The round marks the largest by an AI startup this year, per Crunchbase data. Freenome , $254M, biotech: This is just one of many big biotech raises this month.
That year saw healthcare and biotech as the leading sector, with $20 billion invested in companies with a female founder. Women have founded some of the most significant companies in the new wave of generativeAI. Above $30 billion since 2021 Although female startup founders in the U.S. Data reported is as of May 29, 2024.
Other industry sectors should keep a close eye on the critical milestones and pitfalls of the biotech/healthcare space - with an eye toward what platform, product, service innovations, and architectures may have a potable value proposition within your industry. Details here.
Whatfix , $125M, information technologies: Whatfix locked up a $125 million Series E led by private equity firm Warburg Pincus. Large enterprises deploy these platforms to help their employees more effectively use new technology tools. Founded in 2019, the company has raised $330 million, per Crunchbase.
Liquid AI , $250M, artificial intelligence: What would a week be without a big generativeAI raise? Liquid AI locked up a whopping $250 million round led by AMD at a $2.3 This one goes to Burbank, California-based Zest AI, which landed a $200 million growth investment from Insight Partners.
They proceeded to use another set of AI models to identify molecules which could disrupt the activity of the target protein. This second step involved the relatively new type of AI that is called generativeAI. These are familiar to us all from ChatGPT and GPT-4: GPT stands for Generative Pre-trained Transformer.
While it’s too early to say venture funding will again increase in the sector this year, it is evident investors see the potential in both quantum technology and its ability to produce big financial returns. Kore.ai , $150M, artificial intelligence: Of course there’s a big round for a generativeAI startup.
Table of contents Late stage and technology growth Early stage Seed stage Exits IPOs M&A Adieu, 2024 Related reading Methodology Glossary of funding terms Late stage and technology growth Well start with late- and technology growth-stage, since thats where most of the money goes. Autonomous driving technology developer Pony.ai
After 2 months in an underground shelter they have also used their technology to register evidence of war crimes and provide the ability to immerse oneself into Ukraine to experience it, it’s now developing applications for psychological trauma treatment, VR medical trainin, combat surveillance systems and making the de-mining process safer.
The largest rounds this year to VC-backed startups in Israel include: In June, InSightec , a developer of ultrasound technology devices for image-guided acoustic surgery, raised a $150 million private equity round. Despite that, startups seemingly have still been able to secure money — a lot of it in some cases.
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content